-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CRNXcp5bjYyR5mCP68leg8ZxHoP1QpO836wEXP2QlgoUcM2KB7CqNr2o7Jy/Js7X Wre/TdFJaWaC+tpULNgk5Q== 0001209191-09-024510.txt : 20090505 0001209191-09-024510.hdr.sgml : 20090505 20090505171450 ACCESSION NUMBER: 0001209191-09-024510 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090402 FILED AS OF DATE: 20090505 DATE AS OF CHANGE: 20090505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCCULLOGH ROBERT F JR CENTRAL INDEX KEY: 0001341597 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-00935 FILM NUMBER: 09798527 MAIL ADDRESS: STREET 1: P.O. BOX 151 CITY: KENTFIELD STATE: CA ZIP: 94914 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytoCore Inc CENTRAL INDEX KEY: 0000075439 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 364296006 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 414 NORTH ORLEANS STREET STREET 2: SUITE 502 CITY: CHICAGO STATE: IL ZIP: 60610 BUSINESS PHONE: 4078490290 MAIL ADDRESS: STREET 1: 414 NORTH ORLEANS STREET STREET 2: SUITE 502 CITY: CHICAGO STATE: IL ZIP: 60610 FORMER COMPANY: FORMER CONFORMED NAME: MOLECULAR DIAGNOSTICS INC DATE OF NAME CHANGE: 20011009 FORMER COMPANY: FORMER CONFORMED NAME: AMPERSAND MEDICAL CORP DATE OF NAME CHANGE: 19990527 FORMER COMPANY: FORMER CONFORMED NAME: BELL NATIONAL CORP DATE OF NAME CHANGE: 19920703 4 1 c84851_4x0.xml MAIN DOCUMENT DESCRIPTION X0303 4 2009-04-02 0000075439 CytoCore Inc CYOE.OB 0001341597 MCCULLOGH ROBERT F JR C/O CYTOCORE, INC. 414 N. ORLEANS ST. SUITE 510 CHICAGO IL 60654 1 1 0 0 CEO and CFO Common stock, $.001 par value 2009-04-02 4 P 0 3000 0.47 A 547417 D Common Stock, $ .001 par value 2009-04-09 4 P 0 5000 0.45 A 552417 D Common Stock, $ .001 par value 2009-04-10 4 P 0 5000 0.45 A 557417 D Common Stock, $ .001 par value 2009-04-17 4 P 0 4000 0.41 A 561417 D Common Stock, $ .001 par value 2009-04-24 4 P 0 5000 0.34 A 566417 D Common Stock, $ .001 par value 2009-04-29 4 P 0 400000 0.25 A 966417 D Common Stock, $ .001 par value 2009-04-29 4 M 0 25000 0.25 A 991417 D Common Stock, $ .001 par value 2009-04-29 4 X 0 37500 0.25 A 1028917 D Common Stock, $ .001 par value 2009-04-29 4 X 0 12500 0.25 A 1041417 D Common Stock, $ .001 par value 2009-04-29 4 M 0 10000 0.25 A 1051417 D Common Stock, $ .001 par value 2009-03-11 4 A 0 59459 A 1110876 D Common Stock, $ .001 par value 1242950 I See footnote Common Stock, $ .001 par value 158705 I See footnote Common stock warrant 0.25 2009-04-29 4 M 0 400000 0 D 2007-01-01 2009-09-28 Common stock 400000 0 D Common stock warrant 0.25 2009-04-29 4 M 0 25000 0 D 2007-02-12 2010-02-12 Common stock 25000 0 D Common stock warrant 0.25 2009-04-29 4 X 0 37500 0 D 2008-01-22 2011-01-22 Common stock 37500 0 D Common stock warrant 0.25 2009-04-29 4 X 0 12500 0 D 2008-02-01 2011-02-01 Common stock 12500 0 D Common stock warrant 0.25 2009-04-29 4 M 0 10000 0 D 2008-04-01 2011-04-01 Common stock 10000 0 D Shares acquired upon exercise of warrant issued to the Reporting Person as compensation. Original exercise price was $1.28 per share. Issuer permitted the Reporting Person to exercise at $0.25 per share under an offering to all warrant holders to exercise at a reduced exercise price. Shares acquired upon exercise of warrant issued to the Reporting Person as compensation. Original exercise price was $2.60 per share. Issuer permitted the Reporting Person to exercise at $0.25 per share under an offering to all warrant holders to exercise at a reduced exercise price. Shares acquired upon exercise of warrant issued to the Reporting Person in connection with his participation in a private placement by Issuer. Original exercise price was $2.00 per share. Issuer permitted the Reporting Person to exercise at $0.25 per share under an offering to all warrant holders to exercise at a reduced exercise price. Shares acquired upon exercise of warrant issued to the Reporting Person in connection with his participation in a private placement by Issuer. Original exercise price was $2.00 per share. Issuer permitted the Reporting Person to exercise at $0.25 per share under an offering to all warrant holders to exercise at a reduced exercise price. Shares acquired upon exercise of warrant issued to the Reporting Person as compensation. Original exercise price was $2.06 per share. Issuer permitted the Reporting Person to exercise at $0.25 per share under an offering to all warrant holders to exercise at a reduced exercise price. Shares issued to Reporting Person as compensation in lieu of cash salary. Shares owned by Summitcrest Capital L.P., of which the Reporting Person is the President of the General Partner. Shares owned by MJM Educational Trust (12,500), PFM Educational Trust (12,500), CFM Educational Trust (12,500), and MPC Trust (121,205), of which such trusts the Reporting Person is a trustee. /s/ Robert F McCullough Jr. 2009-05-05 -----END PRIVACY-ENHANCED MESSAGE-----